Sanger Arrayed CRISPR Screening in partnership with Evotec

WEBINAR

Abstract

CRISPR Cas9 nucleases have revolutionized the field of gene editing and high-throughput lentiviral screens continue to hold ever-increasing promise for both basic research and development of future therapies to benefit human health. Even with such powerful technologies at hand, researchers new to the field may find screening of multiple targets to be challenging and time-consuming. This webinar discusses the Evotec partnership between us and the screening services for drug discovery.

What Will You Learn?

• Introduction to CRISPR pooled and arrayed screening concepts
  
• Target identification with Lentiviral CRISPR KO libraries for the discovery of disease relevant genes
• Evotec partnership highlights phenotypic screening capabilities across therapeutic areas

Who Should Watch?

Post-Docs, Managers, Scientists, Clinicians, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Contract Research Labs and Technology Providers involved in Target Discovery, Disease Modeling, Functional Screening, High-Throughput Screening, Assay Development and Translational Research.